Baseline urinary osteopontin levels are associated with the improvement of metabolic syndrome.

Margherita MorieroDaniela VerzolaMaria BertolottoSilvia MinettiPaola ContiniDavide RamoniLuca LiberaleRoberto PontremoliFrancesca ViazziAldo PendeLivia PisciottaFabrizio MontecuccoFederico Carbone

Published in: Nutrition, metabolism, and cardiovascular diseases : NMCD (2024)

Our findings offer insights into potential applications in cardiometabolic medicine for uOPN, which is easily detectable in non-invasive biological samples through an affordable assay.

Keyphrases

metabolic syndrome
high throughput
insulin resistance
uric acid
human health
type diabetes
cardiovascular disease
climate change